• November 19, 2026

By Hassan Zaggi

The National Institute for Cancer Research and Treatment (NICRAT) was established through its Establishment Act 2017. It, however, began full operations in 2023.

The establishment of the Institute represents what many experts in the cancer space described as a critical, systematic response to strengthening oncology research, data collection, and patients care infrastructure.

The strategic focus of the Institute was clear. It includes policy advisory in cancer prevention, treatment and control; regulate and enhance access to cancer care in Nigeria; research and development in cancer prevention and control; resource mobilization for cancer prevention and control; establish and maintain cancer registry; public education and awareness creation in cancer and capacity development in cancer prevention and control.

The appointment of a season oncologist, Prof. Usman Malami Aliyu, to serve as the institute’s  pioneer Director General/Chief Executive Office was widely commended by stakeholders in the cancer space in the country, describing it a square spec in a square hole.

Since assumption of office a little over three years ago, the Institute has made remarkable impact in the fight against all forms of cancers through the introduction of policies and programmes.

It also demonstrated consistent commitment and interest in protecting the health of women and young girls through various initiatives.

The  Institute has also made efforts to tackle the most common  women-related cancers in the country – (breast, cervical, and ovarian), and provide the needed solution in the area of prevention, research and treatment.

 

 

HPV Vaccine

In a deliberate move to halt the spread of female related cancers, the Prof. Malami-led team came up with a strategy to ensure that young girls from age 9-14 in the country are prevented from coming in contact with cervical cancer which is the second most common cancers among women.

To achieve this, the Institute partnered with the National Primary Health Care Development Agency (NPHCDA) to successfully launch the well-celebrated Human Papilloma Virus (HPV) vaccination campaign aimed at preventing cervical cancer in young girls across the country. Currently, over 15 million young girls in all parts of the country have been vaccinated.

While the nationwide campaign is still on going, the HPV vaccine is currently available in major public and private clinics in all parts of the country.

Cervical Cancer

The Prof. Malami-led team also went a step further in the fight against cervical cancer to launch the cervical cancer elimination campaign initiative. The target of the campaign is to eliminate cervical cancer as a public health problem by 2030.

Underscoring the importance attached to the initiative, the Director General of NICRAT in 2024 inaugurated a 15-member National Task Force on Cervical Cancer Elimination (NTF-CCE) under the leadership of the former Minister of Health, Prof. Isaac Adewole, to ensure the implementation of the program.

The NTF-CCE is to drive the cervical cancer elimination campaign aimed at screening 50 per cent of eligible women and treating 100 per cent of detected precancerous lesions by 2027.

The NTF-CCE is crucial to achieving the ambitious goals outlined in the National Strategic Plan for Control of Cervical Cancer 2023-2027.

Some of the specific terms of reference of the Task Force include providing expert guidance, mobilising resources, and leading a nationwide effort to significantly reduce the impact of cervical cancer in the country.

The NTF-CCE is also saddled with the responsibility of implementing the training of public and private healthcare providers in cervical cancer screening and treatment in the six geo-political zones of Nigeria. It will also collaborate with the relevant national and sub-national agencies to provide the infrastructural requirements for sampling, testing, and treatment.

The Task Force is also mandated to establish a ‘basket fund’ to pool and administer funds, donations and grants secured from the government, private sector, philanthropic organisations, development partners and NGOs for the effective implementation of the programme.

The program had since been flagged-off in Imo state for the South-East while plans have been concluded to expand it across six initial pilot states including Niger, Bauchi, Rivers, Ogun, and Sokoto.

Breast Cancer

As a preventive measure against breast cancer, the Institute has bought and distributed mammography equipment to  major hospitals across the country.

Also, in order to encourage and support regular breast cancer screening among women at all levels, NICRAT has integrated cancer screening into family planning services in some states of the country.  The initiative is being expanded to other states. This intervention has led to increased breast cancer screening uptake among women in the pilot states.

At regular intervals, the Institute organizes breast cancer screening for women in different part of the country. For examples, during the World Cancer Day 2025, close to one million women benefitted from free breast and cervical screenings in different parts of the country.

 

Ovarian cancer

In 2025, NICRAT in partnership with the World Ovarian Cancer Coalition launched an initiative christened: Enhancing Prevention, Early Diagnosis, and Treatment of Ovarian Cancer: A Pilot Initiative in Nigeria.

Ovarian cancer is the most dangerous gynecologic cancer worldwide. Unfortunately, it is often diagnosed at an advanced stage due to low awareness and limited access to specialised care.

Over 70% of those diagnosed with ovarian cancer live in low- and middle-income countries. In Nigeria, however, awareness of ovarian cancer is significantly lower than the global average, with 38.8% of Nigerian women having never heard of the disease.

The initiative was targeted at increasing ovarian cancer awareness by 10% among women above 40 years of age and healthcare workers; equip 60 frontline healthcare workers with standardized skills for ovarian cancer detection and referral; reduce average diagnosis time from 6 months to 4 weeks for 80% of suspected cases and increase access to molecular and genetic diagnostic tests by 10%.

Also, in an effort to shift cancer control from a reactive model to a proactive, routine clinical service, the Institute organised free cancer screening and awareness creation campaigns in different parts of the country.

The free cancer screening efforts got a boost recently, when the Nigeria Governors Spouses’ Forum (NGSF) agreed to collaborate with NICRAT to improve access to cancer screening among Nigerians through the National Initiative for Cancer Early Detection, Screening and Coordinated Access to Networked Care (NICE-SCAN).

Capacity building

In the area of capacity building for medical and health workers, over 100 female health care workers have been trained to support early detection through screening, counselling and other community interventions. This capacity building across Primary Health centers  were carried out in many states  of the country.

Since the establishment of the Institute, the Prof. Malami-led management team prioritizes capacity building in an effort to geometrically improve the number of oncology workforce in the country.

Currently, close to 2000 oncology experts drawn from all levels of healthcare have been trained and retrained in all parts of the country since the past three years of the Institute’s establishment. This effort is aimed at ensuring that oncology experts are accessible in all nooks and crannies of the country.

Prioritizing early detection as a cornerstone of cancer survival, the Institute has commissioned eight specialized oncology clinics nationwide. This expanded care network spans the Federal Medical Centres in Abuja and Ebute-Meta, Lagos, as well as major University Teaching Hospitals in Benin, Enugu, Sokoto, Gombe, Kano, and Ile-Ife.

In order to further expand access to cancer care and treatment, which, before now was extremely difficult, NICRAT recently expanded the network of the Nigeria Cancer Access Partnership (NCAP) program from 18 to 25 centres in the country. The Institute has also concluded plans to upgrade one chemotherapy suite in each geopolitical zone of the country.

Demonstrating an uncommon commitment to women’s health, the Federal Government’s flagship Cancer Health Fund (CHF) which is currently domiciled in NICRAT continues to provide huge financial relief primarily targeting breast and cervical cancers for many indigent less privilege patients in the country.

Through CHF, many women in different parts of the country have successfully accessed comprehensive cancer care across six specialized oncology centers strategically located within the  six geopolitical zones of the country.

With the huge investment currently being by the federal government in the fight against cancer in Nigeria, it is evident that there is a better future in terms of the fight against the disease both in the area of prevention, research and treatment.

This, therefore, calls for support from all Nigerians and international partners to enable NICRAT succeed in protecting the health of women and other vulnerable Nigerians.

(Zaggi is a Health Sector analyst and Head, Media and Public Relations, NICRAT)